228 related articles for article (PubMed ID: 10763820)
1. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.
Mussman JG; Horn HF; Carroll PE; Okuda M; Tarapore P; Donehower LA; Fukasawa K
Oncogene; 2000 Mar; 19(13):1635-46. PubMed ID: 10763820
[TBL] [Abstract][Full Text] [Related]
2. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway.
Tarapore P; Horn HF; Tokuyama Y; Fukasawa K
Oncogene; 2001 May; 20(25):3173-84. PubMed ID: 11423967
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase control of centrosome duplication.
Lacey KR; Jackson PK; Stearns T
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2817-22. PubMed ID: 10077594
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
5. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression.
Carroll PE; Okuda M; Horn HF; Biddinger P; Stambrook PJ; Gleich LL; Li YQ; Tarapore P; Fukasawa K
Oncogene; 1999 Mar; 18(11):1935-44. PubMed ID: 10208415
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle: driving the centrosome cycle.
Winey M
Curr Biol; 1999 Jun; 9(12):R449-52. PubMed ID: 10375518
[TBL] [Abstract][Full Text] [Related]
7. P53, cyclin-dependent kinase and abnormal amplification of centrosomes.
Fukasawa K
Biochim Biophys Acta; 2008 Sep; 1786(1):15-23. PubMed ID: 18472015
[TBL] [Abstract][Full Text] [Related]
8. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
9. Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells.
Hanashiro K; Kanai M; Geng Y; Sicinski P; Fukasawa K
Oncogene; 2008 Sep; 27(40):5288-302. PubMed ID: 18490919
[TBL] [Abstract][Full Text] [Related]
10. Loss of p53 and centrosome hyperamplification.
Tarapore P; Fukasawa K
Oncogene; 2002 Sep; 21(40):6234-40. PubMed ID: 12214254
[TBL] [Abstract][Full Text] [Related]
11. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
[TBL] [Abstract][Full Text] [Related]
12. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation.
Minella AC; Swanger J; Bryant E; Welcker M; Hwang H; Clurman BE
Curr Biol; 2002 Oct; 12(21):1817-27. PubMed ID: 12419181
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
14. Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.
Tarapore P; Tokuyama Y; Horn HF; Fukasawa K
Oncogene; 2001 Oct; 20(47):6851-63. PubMed ID: 11687964
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.
Okuda M; Horn HF; Tarapore P; Tokuyama Y; Smulian AG; Chan PK; Knudsen ES; Hofmann IA; Snyder JD; Bove KE; Fukasawa K
Cell; 2000 Sep; 103(1):127-40. PubMed ID: 11051553
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells.
Matsumoto Y; Hayashi K; Nishida E
Curr Biol; 1999 Apr; 9(8):429-32. PubMed ID: 10226033
[TBL] [Abstract][Full Text] [Related]
18. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin.
Gilmour SK; Birchler M; Smith MK; Rayca K; Mostochuk J
Cell Growth Differ; 1999 Nov; 10(11):739-48. PubMed ID: 10593650
[TBL] [Abstract][Full Text] [Related]
19. The role of nucleophosmin in centrosome duplication.
Okuda M
Oncogene; 2002 Sep; 21(40):6170-4. PubMed ID: 12214246
[TBL] [Abstract][Full Text] [Related]
20. Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells.
David-Pfeuty T; Nouvian-Dooghe Y; Sirri V; Roussel P; Hernandez-Verdun D
Oncogene; 2001 Sep; 20(42):5951-63. PubMed ID: 11593402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
